NKGen Biotech, Inc. Warrants
NKGNW
NKGNW was delisted on the 4th of March, 2025.
35 hedge funds and large institutions have $1.72M invested in NKGen Biotech, Inc. Warrants in 2022 Q2 according to their latest regulatory filings, with 6 funds opening new positions, increasing their positions, 1 reducing their positions, and 2 closing their positions.
200% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 2
13% more funds holding
Funds holding: 31 → 35 (+4)
41% less capital invested
Capital invested by funds: $2.94M → $1.72M (-$1.22M)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Parallax Volatility Advisers
San Francisco,
California
|
+$10.4K |
| 2 |
PI
PEAK6 Investments
Chicago,
Illinois
|
+$8.74K |
| 3 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$6.38K |
| 4 |
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System
Harrisburg,
Pennsylvania
|
+$3.96K |
| 5 |
CS
Clear Street
New York
|
+$127 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$11K |
| 2 |
FLC
Fifth Lane Capital
Austin,
Texas
|
-$911 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
GF
26
Gabelli Funds
Rye,
New York
| $5K | – | – | – |
|
27
JP Morgan Chase
New York
| $5K | – | – | – |
|
|
SC
28
Sculptor Capital
New York
| $5K | – | – | – |
|
|
VCIM
29
Velan Capital Investment Management
Alpharetta,
Georgia
| $5K | – | – | – |
|
|
GCIA
30
Gabelli & Co Investment Advisers
Rye,
New York
| $4K | – | – | – |
|
|
CCM
31
CAAS Capital Management
New York
| $3K | – | – | – |
|
32
Walleye Capital
New York
| $3K | – | – | – |
|
|
COPPSERS
33
Commonwealth of Pennsylvania Public School Employees Retirement System
Harrisburg,
Pennsylvania
| $3K | +$3.96K | +10,000 | New |
|
|
FLC
34
Fifth Lane Capital
Austin,
Texas
| $2K | -$911 | -2,300 | -23% |
|
|
MF
35
Magnetar Financial
Evanston,
Illinois
| $4 | +$6.38K | +16,120 | New |
|
|
SCC
36
Spring Creek Capital
Wichita,
Kansas
| – | -$56K | -92,040 | Closed |
|
|
37
Bank of America
Charlotte,
North Carolina
| – | -$11K | -20,000 | Closed |
|
|
CS
38
Clear Street
New York
| – | +$127 | +320 | New |
|
NKGNW Hedge Fund Activity: Q2 2022 in Review
35 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in NKGen Biotech, Inc. Warrants (NKGNW) for Q2 2022, worth a combined $1.72M — down 41% from $2.94M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new NKGNW positions and 2 closed out — a net gain of 4 holders — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Parallax Volatility Advisers, opening a new position worth an estimated $10.4K. The largest seller was Bank of America, exiting entirely with an estimated $11K sold.
- 35 institutional investors held NKGen Biotech, Inc. Warrants (NKGNW) as of Q2 2022, up from 31 in Q1 2022.
- Funds reported $1.72M of NKGen Biotech, Inc. Warrants stock for Q2 2022, down 41% quarter-over-quarter.
- 6 funds opened new NKGen Biotech, Inc. Warrants positions in Q2 2022 and 2 closed out, a net change of +4 holders.
- The largest NKGen Biotech, Inc. Warrants buyer in Q2 2022 was Parallax Volatility Advisers, an estimated $10.4K added.
- The largest NKGen Biotech, Inc. Warrants seller in Q2 2022 was Bank of America, an estimated $11K sold.
Based on aggregated 13F filings for Q2 2022.